Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year.

van der Linde, Riana; Gatt, Prudence N; Smith, Sandy; Fernandez, Marian A; Vaughan, Lachlin; Blyth, Emily; Curnow, Jennifer; Brown, David A; Tegg, Elizabeth; Sasson, Sarah C

van der Linde, Riana; Gatt, Prudence N; Smith, Sandy; Fernandez, Marian A; Vaughan, Lachlin; Blyth, Emily; Curnow, Jennifer; Brown, David A; Tegg, Elizabeth; Sasson, Sarah C.

Affiliation

van der Linde R; Department of Laboratory Haematology, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
Gatt PN; Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Camperdown, NSW 2050, Australia.
Smith S; Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Camperdown, NSW 2050, Australia.
Fernandez MA; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia.
Vaughan L; Flow Cytometry Unit, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
Blyth E; Flow Cytometry Unit, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
Curnow J; Department of Laboratory Haematology, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
Brown DA; Department of Haematology, Western Sydney Local Health District, Westmead Hospital, Westmead, NSW 2145, Australia.
Tegg E; Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Camperdown, NSW 2050, Australia.
Sasson SC; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia.

Cancers (Basel) ; 15(20)2023 Oct 19.

Article de En | MEDLINE | ID: mdl-37894431

Mots clés

AML; B-ALL; MRD; measurable residual disease; minimal residual disease; molecular MRD

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Australie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google